<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="26536">Retinoic acid</z:chebi> (RA) suppressed the production of interferon (IFN) alpha and IFN gamma of human peripheral blood leukocytes in response to stimulation with lectin <z:chebi fb="0" ids="52290">mitogens</z:chebi>, <z:mp ids='MP_0001794'>bacterial</z:mp> products, synthetic <z:chebi fb="1" ids="15986">polynucleotides</z:chebi>, viruses, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>Virus-induced secretion of IFN alpha of human lymphoblastoid cells was also inhibited </plain></SENT>
<SENT sid="2" pm="."><plain>RA-mediated suppression was dose-dependent and required the near-concurrent addition of RA and inducers to human leukocyte cultures, thus suggesting that RA affects an early cellular function in the generation of IFN </plain></SENT>
<SENT sid="3" pm="."><plain>Implications of these findings for the use of <z:chebi fb="0" ids="26537">retinoids</z:chebi> in the treatment of human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> are discussed </plain></SENT>
</text></document>